Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Rectal dosing of DIMS-0150 improves clinical and histological remission in UC trial

Nov. 24, 2009

Deguelin inhibits tumor growth in human colon cancer xenograft mouse model

Nov. 24, 2009

Bosentan inhibits the development of pulmonary vascular lesions in hypoxic mice

Nov. 24, 2009

GM-CSF-expressing adenoviral vector shows clinical benefit in advanced solid tumors

Nov. 24, 2009

RO-5068760 exhibits potent preclinical antitumor activity in B-Raf V600E mutant tumors

Nov. 24, 2009

VER-155008 potentiates Hsp90 inhibitor-induced apoptosis in vitro

Nov. 24, 2009

Atorvastatin improves eGFR regardless of metabolic syndrome state in CHD patients

Nov. 23, 2009

ATI-2042 effective at reducing atrial fibrillation burden in phase II trial

Nov. 23, 2009

AdCD40L immunotherapy for bladder cancer deemed safe in phase I/IIa trials

Nov. 23, 2009

AT-13387 shows promising antitumor activity in mouse xenograft models

Nov. 23, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...